H19 and chronic myelogenous leukemia, BCR-ABL1 positive: RT-qPCR results confirmed significant downregulation of LNC000093 in imatinib-resistant CML cells (Figure 1I; P < 0.01) and, conversely, upregulation of H19 (Figure 1C; P < 0.01) and another novel lncRNA, LNC000114 (Figure 1I; P < 0.01).